ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 59 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,510,223 | $19,727,000 | 1.35% |
| Foresite Capital Management IV, LLC | 804,446 | $2,880,000 | 1.04% |
| EcoR1 Capital, LLC | 2,172,883 | $7,779,000 | 0.72% |
| DAFNA Capital Management LLC | 246,900 | $884,000 | 0.38% |
| BAILARD, INC. | 228,000 | $816,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,415 | $6,320,000 | 0.05% |
| Seelaus Asset Management LLC | 14,300 | $51,000 | 0.05% |
| Hudson Bay Capital Management LP | 650,000 | $2,327,000 | 0.03% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,040,900 | $14,466,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 71,560 | $256,000 | 0.01% |